AMN Stock Forecast & Price Target

AMN Healthcare Services is positioned favorably because 3Q26 revenue of $717.3M beat guidance by a wide margin, aided by $59M of labor disruption revenue versus the expected $7M-$8M, while normalized Nurse and Allied revenue still grew 15% Y/Y and EBITDA remained solid at $94M. Underneath the noise, demand is improving with traveler volume at 9.5K, management saying October demand improved ~70% from the February lows, and productivity reaching all-time highs, supporting stronger operating leverage as the core staffing franchise stabilizes. The positive outlook is further supported by five businesses returning to growth, Nurse and Allied representing about 60% of composite segment EBIT in 2027, and management’s indication that Q4 guidance of $655M-$670M and 1Q27 EBITDA should stay near 4Q levels.

AMN Healthcare Services is facing a deteriorating demand backdrop as health systems continue shifting toward core staffing and away from temporary labor, making the company’s revenue and profit assumptions look increasingly aggressive. Management already expects segment revenue to be flat to down 2% year over year in Q2, and excluding labor disruption revenue that implies a sequential decline of 8% to 10% from Q1, while organic segment revenue fell 4% in 2025 and is modeled to decline another 4% in 2026. The longer-term outlook is further pressured by an 8% drop in days filled in 2025, a modeled 9% decline in 2026, and VMS revenue that has fallen at a 35% CAGR between 2022 and 2025, with downside risk from contract compression, a larger supply of nurses, and customer concentration.